United States Biotechnology & Medical Research

Dogwood Therapeutics Inc (DWTX)

Track

Track

Ticker: DWTX Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Dogwood Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.8
Pridgen William Non-Executive Director
Transaction date
Purchase
Price
289.13
Quantity 65,815 +27.0%
Value US$4,787,475
2.1
Duncan Gregory Scott CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Purchase
Price
290.93
Quantity 4,306 -38.2%
Value US$1,128,259
1.6
Whitley Richard James Non-Executive Director
Transaction date
Sale
Price
335.62
Quantity 13,420 -20.3%
Value US$3,105,016
2.1
Duncan Gregory Scott CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Purchase
Price
4.52
Quantity 7,500 +30.0%
Value US$33,900
1.8
Walsh Angela SVP OF FINANCE Officer
Transaction date
Purchase
Price
4.58
Quantity 2,000 +200.0%
Value US$9,150
1.6
Whitley Richard James Non-Executive Director
Transaction date
Purchase
Price
4.53
Quantity 500 +25.0%
Value US$2,262
2.8
Pridgen William Non-Executive Director
Transaction date
Purchase
Price
4.50
Quantity 241 +0.7%
Value US$1,084
2.8
Pridgen William Non-Executive Director
Transaction date
Purchase
Price
4.38
Quantity 13,450 +58.4%
Value US$58,914
2.8
Pridgen William Non-Executive Director
Transaction date
Purchase
Price
4.94
Quantity 600 +2.7%
Value US$2,964
2.8
Pridgen William Non-Executive Director
Transaction date
Purchase
Price
5.46
Quantity 2,197 +10.9%
Value US$12,002
2.8
Pridgen William Non-Executive Director
Transaction date
Purchase
Price
5.98
Quantity 4,180 +28.7%
Value US$24,998
1.4
De La Rosa Abel Non-Executive Director
Transaction date
Purchase
Price
5.90
Quantity 4,000 +inf%
Value US$23,584
1.6
Whitley Richard James Non-Executive Director
Transaction date
Purchase
Price
5.72
Quantity 1,800 +900.0%
Value US$10,296
1.5
Keefer David R Non-Executive Director
Transaction date
Purchase
Price
5.80
Quantity 5,000 +inf%
Value US$28,975
3.2
Thomas John C Non-Executive Director
Transaction date
Purchase
Price
5.65
Quantity 1,000 +inf%
Value US$5,650
2.8
Pridgen William Non-Executive Director
Transaction date
Purchase
Price
5.43
Quantity 2,215 +18.0%
Value US$12,034
1.6
Whitley Richard James Non-Executive Director
Transaction date
Purchase
Price
5.73
Quantity 200 +inf%
Value US$1,145
2.8
Pridgen William Non-Executive Director
Transaction date
Purchase
Price
5.66
Quantity 8,827 +252.2%
Value US$49,997
2.1
Duncan Gregory Scott CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Purchase
Price
5.52
Quantity 5,000 +25.0%
Value US$27,615
2.1
Duncan Gregory Scott Chief Executive Officer Executive Director
Transaction date
Planned purchase
Price
6.36
Quantity 382 +2.0%
Value US$2,429
2.1
Duncan Gregory Scott Chief Executive Officer Executive Director
Transaction date
Planned purchase
Price
6.17
Quantity 15,675 +401.5%
Value US$96,757
2.8
Pridgen William Non-Executive Director
Transaction date
Purchase
Price
7.47
Quantity 3,500 +inf%
Value US$26,145
1.8
Walsh Angela VP of Finance Officer
Transaction date
Purchase
Price
7.30
Quantity 1,000 +inf%
Value US$7,300
2.8
Pridgen William Non-Executive Director
Transaction date
Purchase
Price
11.98
Quantity 1,500 +0.2%
Value US$17,970
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-08-22 2023-08-21 B Purchase
2.8
Pridgen William
Non-Executive Director
65,815 +27.0%
289.13
US$4,787,475 		65,815 +27.0% 289.13 US$4,787,475
2023-08-18 2023-08-17 B Purchase
2.1
Duncan Gregory Scott

CHIEF EXECUTIVE OFFICER

Executive Director
4,306 -38.2%
290.93
US$1,128,259 		4,306 -38.2% 290.93 US$1,128,259
2022-12-12 2022-12-08 S Sale
1.6
Whitley Richard James
Non-Executive Director
13,420 -20.3%
335.62
US$3,105,016 		13,420 -20.3% 335.62 US$3,105,016
2022-05-24 2022-05-23 B Purchase
2.1
Duncan Gregory Scott

CHIEF EXECUTIVE OFFICER

Executive Director
7,500 +30.0%
4.52
US$33,900 		7,500 +30.0% 4.52 US$33,900
2022-05-24 2022-05-23 B Purchase
1.8
Walsh Angela

SVP OF FINANCE

Officer
2,000 +200.0%
4.58
US$9,150 		2,000 +200.0% 4.58 US$9,150
2022-05-19 2022-05-18 B Purchase
1.6
Whitley Richard James
Non-Executive Director
500 +25.0%
4.53
US$2,262 		500 +25.0% 4.53 US$2,262
2022-05-19 2022-05-18 B Purchase
2.8
Pridgen William
Non-Executive Director
241 +0.7%
4.50
US$1,084 		241 +0.7% 4.50 US$1,084
2022-05-18 2022-05-17 B Purchase
2.8
Pridgen William
Non-Executive Director
13,450 +58.4%
4.38
US$58,914 		13,450 +58.4% 4.38 US$58,914
2022-03-30 2022-03-29 B Purchase
2.8
Pridgen William
Non-Executive Director
600 +2.7%
4.94
US$2,964 		600 +2.7% 4.94 US$2,964
2022-03-24 2022-03-23 B Purchase
2.8
Pridgen William
Non-Executive Director
2,197 +10.9%
5.46
US$12,002 		2,197 +10.9% 5.46 US$12,002
2022-01-28 2022-01-27 B Purchase
2.8
Pridgen William
Non-Executive Director
4,180 +28.7%
5.98
US$24,998 		4,180 +28.7% 5.98 US$24,998
2022-01-07 2022-01-07 B Purchase
1.4
De La Rosa Abel
Non-Executive Director
4,000 +inf%
5.90
US$23,584 		4,000 +inf% 5.90 US$23,584
2022-01-07 2022-01-06 B Purchase
1.6
Whitley Richard James
Non-Executive Director
1,800 +900.0%
5.72
US$10,296 		1,800 +900.0% 5.72 US$10,296
2022-01-05 2022-01-04 B Purchase
1.5
Keefer David R
Non-Executive Director
5,000 +inf%
5.80
US$28,975 		5,000 +inf% 5.80 US$28,975
2022-01-04 2022-01-04 B Purchase
3.2
Thomas John C
Non-Executive Director
1,000 +inf%
5.65
US$5,650 		1,000 +inf% 5.65 US$5,650
2022-01-04 2022-01-03 B Purchase
2.8
Pridgen William
Non-Executive Director
2,215 +18.0%
5.43
US$12,034 		2,215 +18.0% 5.43 US$12,034
2021-12-23 2021-12-23 B Purchase
1.6
Whitley Richard James
Non-Executive Director
200 +inf%
5.73
US$1,145 		200 +inf% 5.73 US$1,145
2021-12-22 2021-12-21 B Purchase
2.8
Pridgen William
Non-Executive Director
8,827 +252.2%
5.66
US$49,997 		8,827 +252.2% 5.66 US$49,997
2021-12-22 2021-12-21 B Purchase
2.1
Duncan Gregory Scott

CHIEF EXECUTIVE OFFICER

Executive Director
5,000 +25.0%
5.52
US$27,615 		5,000 +25.0% 5.52 US$27,615
2021-04-07 2021-04-06 PP Planned purchase
2.1
Duncan Gregory Scott

Chief Executive Officer

Executive Director
382 +2.0%
6.36
US$2,429 		382 +2.0% 6.36 US$2,429
2021-04-06 2021-04-05 PP Planned purchase
2.1
Duncan Gregory Scott

Chief Executive Officer

Executive Director
15,675 +401.5%
6.17
US$96,757 		15,675 +401.5% 6.17 US$96,757
2021-02-01 2021-01-29 B Purchase
2.8
Pridgen William
Non-Executive Director
3,500 +inf%
7.47
US$26,145 		3,500 +inf% 7.47 US$26,145
2021-02-01 2021-01-28 B Purchase
1.8
Walsh Angela

VP of Finance

Officer
1,000 +inf%
7.30
US$7,300 		1,000 +inf% 7.30 US$7,300
2020-12-21 2020-12-17 B Purchase
2.8
Pridgen William
Non-Executive Director
1,500 +0.2%
11.98
US$17,970 		1,500 +0.2% 11.98 US$17,970
Explore more

More insider trading research around Dogwood Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America